Seasoned Clinical and Medical Affairs Executive with nearly 20 years of experience in medical device innovation, clinical research strategy, and regulatory alignment. Adept at building clinical evidence portfolios, leading cross-functional teams, and accelerating time-to-market for emerging therapies. Recognized for ability to translate complex science into actionable strategy, cultivate high-performing teams, and drive value for investors, regulators, and patients alike. Therapeutic expertise in neuromodulation, migraine, chronic pain, substance use disorders, and mental health.
Established and led a consulting practice delivering end-to-end clinical and medical affairs services to early-stage and growth-phase medical device companies. Supported commercialization and regulatory strategies through the design and execution of clinical trials across diverse therapeutic areas, including orthopedics (implantable spine), peripheral vascular disease, and cardiovascular surgical devices.
Responsible for leading a team of clinical research scientist consultants with diverse responsibilities including clinical trial management and closeout, clinical research representation on product development teams, clinical research protocol development, assimilating medical information to key opinion leaders and other healthcare professionals, scientific/medical communications including development of publication strategies, drafting and submitting abstracts, posters, and manuscripts as well as presenting research study findings at national conferences. Key accomplishments include:
Served as the primary scientific liaison between electroCore and the neurology/headache medicine community for the gammaCore device, a non-invasive vagus nerve stimulator for migraine and cluster headache. Engaged with healthcare professionals to facilitate clinical education, scientific exchange, and evidence-based adoption.
Led clinical evidence generation initiatives and served as a key scientific contributor across multiple clinical programs within the neuromodulation portfolio.
Led the design, execution, and oversight of pre- and post-market clinical trials for neuromodulation therapies, ensuring compliance with regulatory standards and alignment with business objectives.
Led the execution of clinical trial strategy for an implantable device targeting sleep apnea. Oversaw site evaluation, selection, initiation, and close-out while ensuring regulatory compliance and data integrity.